BeautyHealth's Q4 2024 revenue was $83.5 million, a 13.8% decrease year-over-year, driven by lower delivery system sales. The company improved its gross margin to 62.7% and adjusted EBITDA reached $9.0 million. Consumable sales grew, and cost-cutting efforts helped offset revenue declines.
Total revenue for Q4 2024 was $83.5 million, down 13.8% year-over-year.
Gross margin improved to 62.7% from 47.2% in Q4 2023.
Net loss was $10.3 million, slightly worse than $9.4 million in Q4 2023.
Adjusted EBITDA increased to $9.0 million, up from $3.4 million last year.
BeautyHealth expects continued challenges in delivery system sales but aims to stabilize revenue through consumables and cost efficiencies.
Visualization of income flow from segment revenue to net income